WallStreetZenWallStreetZen

NASDAQ: OLMA
Olema Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Olema Pharmaceuticals earnings were -$185.2M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest OLMA earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$53.1M, up 15.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, OLMA reported annual earnings of -$162.5M, with 25.5% growth.

OLMA earnings history

Current Revenue
$0.0
Current Earnings
-$185.2M
Current Profit Margin
0%

OLMA Return on Equity

Current Company
-45.9%
Current Industry
-142%
Current Market
13.5%
OLMA's Return on Equity (-45.9%)... subscribe to Premium to read more.
High Return on Equity Performance

OLMA Return on Assets

Current Company
-41.2%
Current Industry
-13.7%
OLMA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when OLMA announces earnings.

OLMA Return on Capital Employed

Current Company
-38.3%
Current Industry
-9.5%
OLMA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

OLMA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
OLMA-$183.48M-$185.15MN/A-$2.03
TBPH$144.43M$114.54M-93.17%$2.27
DRTS-$41.49M-$42.63MN/A-$0.53
ORIC-$134.03M-$135.21MN/A-$1.41
LXRX-$17.44M-$26.09MN/A-$0.07
View Top Biotech Stocks

Olema Pharmaceuticals Earnings Reports & History FAQ

What were Olema Pharmaceuticals's earnings last quarter?

On OLMA's earnings call on Invalid Date, Olema Pharmaceuticals (NASDAQ: OLMA) reported Q1 2026 earnings per share (EPS) of -$0.52, up 44.44% year over year. Total OLMA earnings for the quarter were -$53.09 million. In the same quarter last year, Olema Pharmaceuticals's earnings per share (EPS) was -$0.36.

If you're new to stock investing, here's how to buy Olema Pharmaceuticals stock.

Is Olema Pharmaceuticals profitable or losing money?

As of the last Olema Pharmaceuticals earnings report, Olema Pharmaceuticals is currently losing money. Olema Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$185.15 million, a 43.65% increase year over year.

What was OLMA's earnings growth in the past year?

As of Olema Pharmaceuticals's earnings date in Invalid Date, Olema Pharmaceuticals's earnings has grown year over year. OLMA earnings in the past year totalled -$185.15 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.